House Oversight Hearing On Prescription Drug Price Increases
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals LLC, smiles while listening to opening statements at a House Committee on Oversight and Government Reform hearing on prescription drug prices in Washington, D.C., U.S., on Thursday, Feb. 4, 2016. Shkreli, who is no longer with Turing and faces federal fraud charges unrelated to the drugmaker, declined to make any comments to the committee. “On the advice of counsel, I invoke my Fifth Amendment,” Shkreli said. Photographer: Pete Marovich/Bloomberg via Getty Images